S[tudies of neutralizing antibodies]{.smallcaps} in HIV-1-infected individuals and in preclinical and clinical trials of candidate vaccines place a heavy reliance on the use of Env-pseudotyped viruses.^[@B1],[@B2]^ These pseudotyped viruses are produced by cotransfecting 293T or other suitable cell lines with an Env expression vector and an Env-defective backbone vector. One popular backbone vector, pSG3Δenv, is a full-length HIV-1 subtype B genome in plasmid pTZ19U that contains a four nucleotide insertion that inactivates the *env* gene (NIH AIDS Reagent Program, catalogue \#11051; contributed by Drs. John C. Kappes and Xiaoyun Wu). Because most of *env* is preserved in this backbone, potential exists for recombination with the cotransfected functional *env* gene to produce replication-competent virus (RCV). The presence of RCV could compromise the neutralization assay by representing an unintended viral target for neutralization. It would also highlight a safety concern for pseudoviruses that are presumed to be replication incompetent and therefore low risk. We tested a large number of assay stocks of HIV-1 Env-pseudotyped viruses made with the SG3Δenv backbone for the presence of RCV. In addition, we tested a subset of these Env-pseudotyped viruses made with HIV-1 subtype A backbone, Q23Δenv, containing a 431 base pair deletion of the V1-C2 region of gp120.^[@B3]^ We also tested a small subset of Env-pseudotyped viruses made with an alternate HIV-1 subtype B backbone, NL4-3.Luc.R^−^E^−^.^[@B4]^ Both backbone vectors are available from the NIH AIDS Reagent Program (Q23Δenv catalogue \#11548, contributed by Dr. Julie Overbaugh; NL4-3.Luc.R^−^E^−^ catalogue \#3418, contributed by Dr. Nathaniel Landau). All Env-pseudotyped viruses were prepared as described.^[@B5]^

Phytohemagglutinin-stimulated human peripheral blood mononuclear cells (PHA-PBMCs) were inoculated with undiluted Env pseudovirus preparations in 96-well round-bottom culture plates in the presence of IL-2.^[@B6]^ PHA-PBMCs were washed after 1 day to remove the virus inoculum and the medium was replaced. Fresh PHA-PBMCs were added on day 7. Cultures were incubated for 12--14 days with regular changing of the medium every 3 days. Culture fluids from days 7, 10, and the final day of incubation were tested for the presence of p24 Gag antigen (PerkinElmer Life Sciences, Inc., Boston, MA). Culture fluids on the final day of incubation were further tested for infectious virus by transferring 50 μl to 96-well plates containing TZM-bl cells in a total volume of 250 μl/well (this transfer was made before collecting culture fluid for p24 assay). Luciferase reporter activity was measured after two days of incubation as described.^[@B5]^ Samples were considered RCV positive if elevated levels of both p24 Gag antigen and relative luminescence units (RLU) were detected. All assays used the same pool of donor PBMC, which was prescreened and found to be negative for HIV-1.

As seen in [Table 1](#T1){ref-type="table"}, 17% (20/117) of Env-pseudotyped virus preparations tested positive for RCV. Four independent preparations of the subtype B pseudovirus, SF162.LS, were positive when made with the SG3ΔEnv backbone. One of two preparations of this pseudovirus was positive when made with the subtype A backbone, Q23Δenv, whereas two preparations made with the NL4-3.Luc.R^−^E^−^ backbone were both negative. Among six different preparations of subtype B pseudovirus QH0692.42 made with the SG3Δenv backbone, three tested positive for RCV. One of three different preparations of the subtype B pseudovirus THRO4156.18 made with SG3Δenv backbone was positive. In other cases, multiple preparations of the same pseudoviruses made with the SG3Δenv backbone were consistently negative (e.g., AC10.0.29, CAAN5342.A2, REJO4541.67, SC422661.8, TRJO4551.58, TRO.11, and ZM197M.PB7 Envs). Thus, certain Envs appear to have a greater tendency to generate RCV than others. This tendency may also be related to the backbone vector. Thus, nonsubtype B viruses made with the subtype B backbone SG3Δenv were rarely RCV positive (1/41 cases positive, where the only positive was ZM53M.PB12, a subtype C Env). Among seven subtype A pseudoviruses made with the subtype A backbone Q23Δenv, one tested positive and this single positive was an Env that was isogenic to the vector (Q23.17). Overall, of the 20 RCV-positive tests, only two occurred when the subtype of the Env and backbone were mismatched (SF162.LS made with Q23Δenv; ZM53M.PB12 made with SG3Δenv). These results indicate that the potential to generate RCV may be greater when using a backbone that is matched to the subtype of the Env clone. That being said, use of a nonsubtype-matched backbone vector is no guarantee that RCV will be avoided.

###### 

[Test for Replication-Competent Virus in HIV-1 Env-Pseudotyped Virus Preparations]{.smallcaps}

                                                         *p24 (ng/ml)*   *RLU in TZM-bl*               
  ------------------------- -------------------- ------- --------------- ----------------- ----------- ------------
  Q168.a2                   Q23Δenv              AD      2.1             1.2               2.2         2061
  Q168.a2                   Q23Δenv              AD      1.7             0.1               0.1         1317
  Q168.a2                   SG3ΔEnv              AD      0.6             0.2               0.2         1889
  **Q23.17**                **Q23Δenv**          **A**   **39.7**        **47.2**          **123**     **141010**
  Q23.17                    SG3ΔEnv              A       **5.4**         0.2               0.1         1558
  Q259.d2.17                Q23Δenv              A       **3.5**         1.9               **3.6**     1859
  Q259.d2.17                SG3ΔEnv              A       1.8             0.5               0.5         2033
  Q461.e2                   Q23Δenv              AD      **7.2**         **4.1**           **6.6**     2615
  Q461.e2                   SG3ΔEnv              A       1.2             0.4               0.4         2054
  **Q769.d22**              **Q23Δenv**          **A**   **7.8**         **4.3**           **8.2**     **31689**
  Q769.d22                  SG3ΔEnv              A       **3.2**         0.1               0.1         1271
  Q842.d12                  Q23Δenv              A       **3.5**         1.6               **3.1**     1596
  Q842.d12                  SG3ΔEnv              A       0.7             0.1               0.1         1278
  235-47                    SG3ΔEnv              AG      1.7             0.1               0.1         1773
  252-7                     SG3ΔEnv              AG      2.6             0.2               0.1         1942
  263-8                     SG3ΔEnv              AG      1.3             0.1               0.1         1758
  271-11                    SG3ΔEnv              AG      1.4             0.1               0.1         1675
  T251-18                   SG3ΔEnv              AG      **5.4**         0.2               0.1         1736
  T255-34                   SG3ΔEnv              AG      0.6             0.1               0.1         2243
  T257-31                   SG3ΔEnv              AG      0.1             0.1               0.1         1519
  T266-60                   SG3ΔEnv              AG      0.8             0.1               0.1         1412
  T280-5                    SG3ΔEnv              AG      0.8             0.1               0.1         1584
  **6101.1**                **SG3ΔEnv**          **B**   **3.4**         0.5               2.2         **33183**
  6535.3                    Q23Δenv              B       0.1             0.1               0.1         1628
  6535.3                    SG3ΔEnv              B       0.3             0.1               0.1         1600
  **62357.14.D3.4589**      **SG3ΔEnv**          **B**   **3.3**         **7.2**           **7.5**     **119276**
  6240.08.TA5.4622          SG3ΔEnv              B       1               0.4               0.3         2118
  **6244.13.B5.4576**       **SG3ΔEnv**          **B**   **3.7**         **41.4**          **61.1**    **110315**
  6535.3 ID                 SG3ΔEnv              B       0.1             0.1               0.1         2057
  700010040\.C9\.4520       SG3ΔEnv              B       2.2             0.4               0.4         2069
  9021-14.B2.4571           SG3ΔEnv              B       **3.4**         0.9               0.8         2034
  AC10.0.29                 SG3ΔEnv              B       2.4             0.2               0.1         2422
  AC10.0.29                 SG3ΔEnv              B       0.9             0.3               0.4         2062
  AC10.0.29                 SG3ΔEnv              B       0.4             0.2               0.6         1829
  Bal.26                    SG3ΔEnv              B       **4.0**         0.2               0.1         5586
  BB-1006-11.C3.1601        SG3ΔEnv              B       0.4             0.2               0.2         2081
  BB-1012-11.TC21           SG3ΔEnv              B       0.7             0.3               0.2         1952
  **BB-1054-07.TC4.1499**   **SG3ΔEnv**          **B**   **3.3**         **20.5**          **32**      **98849**
  BB-1056-10.TA11.1826      SG3ΔEnv              B       0.5             0.3               0.2         2107
  **BZ167.12**              **SG3ΔEnv**          **B**   **8.6**         **19.9**          **21.3**    **16897**
  CAAN5342.A2               SG3ΔEnv              B       1.1             0.4               0.5         2118
  CAAN5342.A2               SG3ΔEnv              B       1.1             0.8               2.5         3349
  CAAN5342.A2               SG3ΔEnv              B       0.4             0.2               0.5         1816
  **H022.7**                SG3ΔEnv              B       **3.2**         0.1               **3.3**     **9824**
  H030.7 (T2)               SG3ΔEnv              B       2.2             0.1               0.1         1808
  H035.18                   SG3ΔEnv              B       2.2             0.1               0.1         1483
  H077.31 (T1)              SG3ΔEnv              B       2.0             0.1               0.1         1341
  H079.2 (T1)               SG3ΔEnv              B       0.3             0.1               0.1         1238
  **PRB926-04.A9.4237**     **SG3ΔEnv**          **B**   **3.3**         **29.3**          **27**      **119652**
  PVO.4                     Q23Δenv              B       2.4             1.4               2.4         1795
  PVO.4                     SG3ΔEnv              B       0.8             0.3               0.3         2030
  QH0692.42                 Q23Δenv              B       **5.4**         2.9               **5.1**     1529
  **QH0692.42**             **SG3ΔEnv**          **B**   **18.1**        **42.2**          **91.9**    **187048**
  **QH0692.42**             **SG3ΔEnv**          **B**   **6.0**         **142.5**         **198**     **92427**
  QH0692.42                 SG3ΔEnv              B       2.2             0.7               0.8         1940
  **QH0692.42**             **SG3ΔEnv**          **B**   2.1             2                 **3.1**     **10815**
  QH0692.42                 SG3ΔEnv              B       **3.5**         2                 **3.3**     1989
  REJO4541.67               SG3ΔEnv              B       1.0             0.2               0.3         2000
  REJO4541.67               SG3ΔEnv              B       1.9             1.3               2.1         1761
  RHPA.7                    SG3ΔEnv              B       0.7             0.4               0.7         1664
  RHPA4259.7                SG3ΔEnv              B       0.6             0.2               0.3         2028
  SC05.8C11.2344            SG3ΔEnv              B       1.2             0.4               0.3         1988
  SC422661.8                SG3ΔEnv              B       1.3             0.4               0.5         1923
  SC422661.8                SG3ΔEnv              B       1.9             0.8               1.7         1280
  SF162.LS                  NL4-3.Luc.R^−^E^−^   B       0.4             0.3               0.5         2108
  SF162.LS                  NL4-3.Luc.R^−^E^−^   B       0.1             0.1               0.2         1066
  **SF162.LS**              **Q23Δenv**          **B**   **11.7**        **29.9**          **57.1**    **125593**
  SF162.LS                  Q23Δenv              B       1.2             0.7               0.5         1894
  **SF162.LS**              **SG3ΔEnv**          **B**   **343.5**       **122.2**         **70.4**    **221969**
  **SF162.LS**              **SG3ΔEnv**          **B**   **64.7**        **266.1**         **343.3**   **132423**
  **SF162.LS**              **SG3ΔEnv**          **B**   **17.4**        **19.9**          **63.2**    **81844**
  **SF162.LS**              **SG3ΔEnv**          **B**   **4.5**         **38.4**          **132.2**   **197350**
  89.6P.18                  NL4-3.Luc.R^−^E^−^   B       0.1             0.1               0.1         1847
  89.6P.18                  NL4-3.Luc.R^−^E^−^   B       0.01            0.1               0.1         1849
  89.6P.18                  Q23Δenv              B       1.5             0.9               1.5         1932
  **SF162P3.5**             **SG3ΔEnv**          **B**   2.1             **4.4**           **8.1**     **109604**
  SF162P3.5                 SG3ΔEnv              B       0.8             0.3               0.3         2082
  SS1196.1                  SG3ΔEnv              B       1.2             0.1               0.1         2892
  **THRO4156.18**           **SG3ΔEnv**          **B**   **23.6**        **45.6**          **58.3**    **94297**
  THRO4156.18               SG3ΔEnv              B       1.1             0.4               0.5         1878
  THRO4156.18               SG3ΔEnv              B       1               0.6               1.1         1737
  TRJO4551.58               SG3ΔEnv              B       0.6             0.2               0.3         1763
  TRJO4551.58               SG3ΔEnv              B       0.1             0.1               0.1         1890
  TRO.11                    SG3ΔEnv              B       0.6             0.2               0.3         2080
  TRO.11                    SG3ΔEnv              B       0.2             0.2               0.2         1797
  WEAU-d15.410.787          SG3ΔEnv              B       2.4             0.5               0.5         2095
  WITO4160.33               Q23Δenv              B       1.1             0.8               1.4         1826
  WITO4160.33               SG3ΔEnv              B       0.3             0.2               0.2         1984
  CH038.12                  SG3ΔEnv              BC      1.4             0.3               0.4         8835
  CH070.1                   SG3ΔEnv              BC      2.1             0.1               0.1         1675
  CH110.2                   SG3ΔEnv              BC      2.7             0.2               0.1         1644
  CH115.12                  SG3ΔEnv              BC      0.3             0.1               0.1         2036
  CH119.10                  SG3ΔEnv              BC      1.5             0.1               0.1         1657
  CH181.12                  SG3ΔEnv              BC      2.4             0.1               0.1         1705
  97ZA012.12                Q23Δenv              C       0.7             0.4               0.8         1817
  CAP210.2.00.E8            SG3ΔEnv              C       0.3             0.1               0.2         1935
  CAP45.2.00.G3             SG3ΔEnv              C       0.3             0.2               0.2         1993
  Du151.2                   SG3ΔEnv              C       **4.5**         0.2               0.1         1522
  Du156.12                  SG3ΔEnv              C       0.5             0.2               0.2         2008
  DU172.17                  Q23Δenv              C       0.1             0.1               0           1747
  Du172.17                  SG3ΔEnv              C       0.8             0.1               0.1         1821
  Du422.1                   SG3ΔEnv              C       1.8             0.1               0.1         1099
  HIV-0013095-2.11          SG3ΔEnv              C       0.6             0.1               0.1         1554
  HIV-00836-2.5             SG3ΔEnv              C       0.8             0.1               0.1         1303
  HIV-16845-2.22            SG3ΔEnv              C       1.2             0.1               0.1         1594
  HIV-25710-2.43            SG3ΔEnv              C       1.4             0.1               0.1         1631
  HIV-25925-2.22            SG3ΔEnv              C       2.4             0.2               0.1         1759
  ZM106F.PB9                SG3ΔEnv              C       5.0             0.2               0.1         1566
  ZM109F.PB4                SG3ΔEnv              C       0.4             0.2               0.2         1994
  ZM135M.PL10a              SG3ΔEnv              C       0.2             0.1               0.1         2036
  ZM197M.PB7                SG3ΔEnv              C       **7.6**         0.2               0.1         1413
  ZM197M.PB7                SG3ΔEnv              C       0.5             0.2               0.2         1973
  ZM214M.PL15               SG3ΔEnv              C       0.7             0.3               0.2         2074
  ZM233M.PB6                Q23Δenv              C       0.8             0.6               1.2         1296
  ZM233M.PB6                SG3ΔEnv              C       0.2             0.2               0.2         2057
  ZM249M.PL1                SG3ΔEnv              C       0.4             0.2               0.2         1941
  **ZM53M.PB12**            **SG3ΔEnv**          **C**   1.3             **10.3**          **15.8**    **56045**

RLU, values \>9,000 were considered positive and are *bolded*; p24 values \>3 ng/ml were considered positive and are *bolded*. Env-pseudotyped viruses that tested positive for both RLU and p24 are also *bolded*.

PBMC, peripheral blood mononuclear cell; RLU, relative luminescence units.

To confirm that recombination did in fact occur, we repeated a set of PBMC infection assays with three transfection stocks of Env pseudoviruses that tested positive for RCV and determined the Env sequences in the infected PBMC. These repeat tests were performed with the SG3ΔEnv backbone pseudotyped with BZ167.12 and 62357.14.D3.4589 Envs and with the Q23Δenv backbone pseudotyped with SF162.LS Env. All three transfection stocks of pseudoviruses once again tested positive for p24 Gag antigen after 10 days of PBMC infection. Bulk gp160 sequencing of PBMC DNA was performed as described previously.^[@B7]^ Sequence analysis revealed the presence of recombinant gp160 genes in all three cases, where the defective region of the backbone gp160 was replaced with an overlapping region of the pseudotype gp160 ([Fig. 1](#f1){ref-type="fig"}).

![Genetic recombination in replication-competent virus. Shown are the recombination events that occurred between backbone and pseudotyped *env* genes detected in peripheral blood mononuclear cell DNA 10 days after infection with three different transfection stocks of Env-pseudotyped viruses. Backbone Env segments are *shaded gray*. Pseudotyped Env segments are *not shaded*. Nucleotide residues at the borders of mutations (backbone vectors) and regions of recombination are shown above each Env.](fig-1){#f1}

We next tested whether RCV impacted the outcome of neutralization assays performed in TZM-bl cells. Any impact would depend on where the RCV arose (i.e., during transfection or after infection) and how much RCV was present. Any RCV that arose after infection in TZM-bl cells would be of little consequence for an assay that is not incubated long enough to detect multiple rounds of infection. In contrast, if recombination occurred during transfection, the resulting virus would be a mixed population containing the intended Env and a recombinant Env containing elements of the backbone vector. In this latter case, levels of RCV that are sufficient to register in the assay might complicate the results by measuring neutralization of the RCV rather than solely the intended virus.

For our tests, we selected two separate stocks of SF162.LS and one stock of QH0692.42 that scored among the highest RCV values. These transfection stocks of Env-pseudotyped viruses that tested positive for RCV were assayed in parallel with a transfection stock of each Env-pseudotyped virus that tested negative for RCV. All Env-pseudotyped viruses were made with the SG3Δenv backbone except for the RCV-negative stock of SF162.LS, which was made with the NL4-3.Luc.R^−^E^−^ backbone. Assays were performed in TZM-bl cells^[@B5]^ using 13 HIV-1 plasma samples, soluble CD4, and the monoclonal antibodies IgG1b12, 2G12, 2F5, and 4E10. Equivalent neutralization results were obtained with all reagents regardless of RCV status (\<3-fold difference in ID50 neutralization titers between RCV positive and negative pairs of Env-pseudotyped viruses, data not shown). These results indicate that the level of RCV present in these Env-pseudotyped viral preparations had no measurable effect on the TZM-bl neutralization assay.

Regardless of the lack of measurable impact of RCV on the results of neutralization assays, the real potential for RCV to be present at low levels in Env-pseudotyped virus preparations should raise awareness for laboratory personnel who may consider Env-pseudotyped viruses to be less of a risk and, therefore, require a lower level of biosafety than work with replication-competent HIV-1. We strongly recommend that all laboratory procedures with HIV-1 Env-pseudotyped viruses be conducted using the same level of biosafety that is required for work with replication competent HIV-1. At the very least, rigorous testing for RCV should be performed on all pseudovirus preparations before initiating work at a lower biosafety level.
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